Anzeige
Mehr »
Login
Sonntag, 08.09.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Von Null auf 200 Millionen Dollar: Der unaufhaltsame Aufstieg von West Red Lake Gold
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
190 Leser
Artikel bewerten:
(1)

YourBio Health Welcomes New Board Member, Mark Stevenson

MEDFORD, Mass., July 22, 2024 /PRNewswire/ -- YourBio Health, a Boston-based pioneer in remote, capillary whole blood collection technology, announced today that Mark Stevenson has joined the company's Board of Directors. Mr. Stevenson, with his extensive experience in commercializing life sciences and diagnostics innovations globally, is a valuable addition to the Board and will contribute significantly to the company's growth and success.

YourBio Health Logo

Mr. Stevenson is a Senior Partner at Flagship Pioneering. He recently served as Executive Vice President and Chief Operating Officer at Thermo Fisher Scientific, a company with over $40B in sales and a world leader in serving science through leading its life science solutions, analytical instruments, specialty diagnostics, and laboratory products businesses. He joined Thermo Fisher as Executive Vice President and President of Life Sciences Solutions through the acquisition of Life Technologies. During his tenure, he spearheaded several successful product launches and strategic partnerships, significantly contributing to the company's growth. He has also previously served as President and Chief Operating Officer of Life Technologies and President and Chief Operating Officer of Applied Biosystems prior to its merger with Invitrogen Corporation.

"We enthusiastically welcome Mark Stevenson to YourBio Health's Board of Directors," said Paul Owen, President and CEO of YourBio Health. "Mark's deep experience optimizing strategy, innovation, and operations in complex, global life sciences business environments will be invaluable to YourBio Health as we grow our business and pursue our mission to improve the blood collection experience for patients."

"I am pleased to join YourBio Health to help advance the company's mission of expanding access to its pioneering, virtually painless blood collection technology," said Mark Stevenson, Board Director of YourBio Health. "It is an honor to serve alongside my fellow Board members, who share my commitment to this goal."

To learn more, visit yourbiohealth.com.

About YourBio Health
YourBio Health is a Flagship Pioneering portfolio company that invented 'Touch-Activated Phlebotomy' (TAP) for virtually painless whole capillary blood collection using devices incorporating patented technology. This technology eliminates barriers to blood collection by allowing a capillary blood sample to be collected from any physical location without the pain of a fingerstick or the need for traditional phlebotomy. Backed by the latest sciences, data management technology, and certified central laboratories, YourBio Health seeks to revolutionize and humanize the blood collection process serving clinical trials, diagnostic and wellness applications.

Logo - https://mma.prnewswire.com/media/2461303/YBH_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/yourbio-health-welcomes-new-board-member-mark-stevenson-302200822.html

© 2024 PR Newswire
Vorsicht Crash! So sichere ich mein Aktienportfolio aktiv ab

Der schwarze Montag Anfang August, in Folge der temporären Liquidierung des sogenannten „Yen Carry-Trades“, vernichtete Milliarden an Anlegergeldern. Sogenannte Black Swan Events, also Ereignisse, die nichts und niemand vorhersagen kann, traten zuletzt im März 2020 beim Ausbruch der Corona-Pandemie auf.

Doch wie können Sie sich bei einem derartigen Ausverkauf und Verfall Ihres Depots schützen? Im folgenden kostenlosen Spezialreport wird aufgezeigt, wie man sein Depot mit diversen Strategien und den richtigen Instrumenten versichern kann.

Erweitern Sie Ihr Wissen und handeln Sie zukünftig wie die Profis, um vor dem nächsten schwarzen Schwan ihr Kapital in Sicherheit zu bringen.

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.